Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype

British Journal of Haematology

Volumn 131, Issue 1, 2005, Pages 100-108

  Coppola, Antonio ^a   D'Angelo, Armando ^b   Fermo, Isabella ^c   Mazzola, Giuseppina ^b   Minno, Matteo Nicola Dario Di ^a   Cajani, Alessia ^d   Sala, Angelo ^d   Folco, Giancarlo ^d   Tremoli, Elena ^d   Minno, Giovanni Di ^a,e  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCSHS Raffaele   (Italy)

^c University of Milan ^*  (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

5, 10 methylenetetrahydrofolate reductase; 5 methyltetrahydrofolate; 8 iso PGF2 ; Homocysteine; Oxidative stress; Thrombosis

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 677TT METHYLENETETRAHYDROFOLATE; 8 ISOPROSTAGLANDIN F2 ALPHA; CREATININE; FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLIC ACID; PREFOLIC; UNCLASSIFIED DRUG; 11 DEHYDRO THROMBOXANE B2; 11-DEHYDRO-THROMBOXANE B2; 5-METHYLTETRAHYDROFOLATE; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; DRUG DERIVATIVE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PROSTAGLANDIN F2 ALPHA; TETRAHYDROFOLIC ACID DERIVATIVE; THROMBOXANE B2;

ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOLIC ACID BLOOD LEVEL; GENOTYPE; GEOMETRY; HUMAN; MALE; METABOLISM; OXIDATIVE STRESS; PRIORITY JOURNAL; SUPPLEMENTATION; THROMBOSIS; URINARY EXCRETION; BLOOD; CASE CONTROL STUDY; DIET SUPPLEMENTATION; GENETICS; MIDDLE AGED; MUTATION; ONSET AGE; STATISTICAL MODEL; URINE;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; DINOPROST; FEMALE; HOMOCYSTEINE; HUMANS; LINEAR MODELS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; OXIDATIVE STRESS; TETRAHYDROFOLATES; THROMBOSIS; THROMBOXANE B2;

EID: 27744492397     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05732.x     Document Type: Article

References (36)

1. Arnadottir M. Brattstrom L. Simonsen O. Thysell H. Hultberg B. Andersson A. Nilsson-Ehle P. ( 1993) The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clinical Nephrology, 40, 236 240.
2. Awad J.A. Morrow J.D. Takahashi K. Roberts L.J. ( 1993) Formation of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma. Journal of Biological Chemistry, 268, 4161 4169.
3. Baggott J.E. Tamura T. Baker H. ( 2001) Re-evaluation of the metabolism of oral doses of racemic carbon isomers of formyltetrahydrofolate in human subjects. British Journal of Nutrition, 85, 653 657.
4. Brattström L. ( 1996) Vitamins as homocysteine lowering agents. Journal of Nutrition, 126, 1276S 1280S.
5. Christen W.G. Ajani U.A. Glynn R.J. Hennekens C.H. ( 2000) Blood levels of homocysteine and increased risks of cardiovascular disease, causal or casual Archives of Internal Medicine, 160, 422 434.
6. D'Angelo A. Selhub J. ( 1997) Homocysteine and thrombotic disease. Blood, 90, 1 11.
7. 12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events. Thrombosis and Haemostasis, 83, 563 570.
8. Daví G. Di Minno G. Coppola A. Andria G. Cerbone A.M. Madonna P. Tufano A. Falco A. Marchesani P. Ciabattoni G. Patrono C. ( 2001) Oxidative stress and platelet activation in homozygous homocystinuria. Circulation, 104, 1124 1128.
9. Doshi S.N. McDowell I.F. Moat S.J. Lang D. Newcombe R.G. Kredan M.B. Lewis M.J. Goodfellow J. ( 2001) Folate improves endothelial function in coronay artery disease: an effect mediated by reduction of intracellular superoxide Arteriosclerosis, Thrombosis and Vascular Biology, 21, 1196 1202.
10. Doshi S.N. McDowell I.F.W. Moat S.J. Payne N. Durrant H.J. Lewis M.J. Goodfellow J. ( 2002) Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation, 105, 22 26.
11. Eberhardt R.T. Forgione M.A. Cap A. Leopold J.A. Rudd M.A. Trolliet M. Heydrick S. Stark R. Klings E.S. Moldovan N.I. Yaghoubi M. Goldschmidt-Clermont P.J. Farber H.W. Cohen R. Loscalzo J. ( 2000) Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. Journal of Clinical Investigation, 106, 483 491.
12. Fermo I. Arcelloni C. De Vecchi E. Viganò D'Angelo S. D'Angelo A. Paroni R. ( 1992) High-performance liquid chromatografic method with fluorescence detection for the determination of total homocyst(e)ine in plasma. Journal of Chromatogrophy, 593, 171 176.
13. Fohr I.P. Prinz-Langenohl R. Bronstrup A. Bohlmann A.M. Nau H. Berthold H.K. Pietrzik K. ( 2002) 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women. American Journal of Clinical Nutrition, 75, 275 282.
14. de Franchis R. Mancini F.P. D'Angelo A. Sebastio G. Fermo I. De Stefano V. Margaglione M. Mazzola G. Di Minno G. Andria G. ( 1996) Elevated total plasma homocysteine and 677C->T mutation of the 5,10 methylenetetrahydrofolate reductase gene in thrombotic vascular disease. American Journal of Human Genetics, 59, 262 264.
15. Frosst P. Blom H.J. Milos R. Goyette P. Sheppard C.A. Matthews R.G. Boers G.J.H. den Heijer M. Kluijtmans L.A.J. van den Heuvel L.P. Rozen R. ( 1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 10, 111 113.
16. Fuchs D. Jaeger M. Widner B. Wirleitner B. Artner-Dworzak E. Leblhuber F. ( 2001) Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake?. Clinical Chemistry and Laboratory Medicine, 39, 691 694.
17. Guttormsen A.B. Ueland P.M. Nesthus I. Nygard O. Schneede J. Vollset S.E. Refsum H. ( 1996) Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (≥40 μmol/liter). Journal of Clinical Investigation, 98, 2174 2183.
18. Homocysteine Lowering Trialists' Collaboration 1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. British Medical Journal, 316, 894 898.
19. Jacques P.F. Bostom A.G. Williams R.R. Ellison R.C. Eckfeldt J.H. Rosenberg I.H. Selhub J. Rozen R. ( 1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase and plasma homocysteine concentration. Circulation, 93, 7 9.
20. Litynski P. Loehrer F. Linder L. Todesco L. Fowler B. ( 2002) Effect of low doses of 5-methyltetrahydrofolate and folic acid on plasma homocysteine in healthy subjects with or without the 677C->T polymorphism of methylenetetrahydrofolate reductase. European Journal of Clinical Investigation, 32, 662 668.
21. Malinow M.R. Nieto F.J. Kruger W.D. Duell P.B. Hess D.L. Gluckman R.A. Block P.C. Holzgang C.R. Anderson P.H. Seltzer D. Upson B. Lin Q.R. ( 1997) The effects of folic acid supplementation on plasma homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 1157 1162.
22. McCaddon A. Regland B. Hudson P. Davies G. ( 2002) Functional vitamin B(12) deficiency and Alzheimer disease. Neurology, 58, 1395 1939.
23. Miller S.A. Dykes D.D. Polesky H.F. ( 1988) A simple salting out procedure for extracting DNA from human nucleated cells [letter]. Nucleic Acid Research, 16, 1215.
24. Patrono C. FitzGerald G.A. ( 1997) Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 2309 2315.
25. Pattini A. Di Salvo V. Schena F. Le Grazie C. ( 1988) Iron values and haematological parameters of cross-country skiers. Effect of iron and 5-methyltetrahydrofolic acid (Prefolic) supplementation. Clinical Trials Journal, 25, 296 307.
26. 2-isoprostanes in hypercholesterolemia. Circulation, 98, 2822 2828.
27. Shane B. ( 1995) Folate chemistry and metabolism. In: Folate in Health and Disease ( ed. by L.B. Bayley pp. 1 22. Marcel Dekker Inc., New York.
28. Stroes E.S.G. van Faassen E.E. Yo M. Martasek P. Govers R. Rabelink T.J. ( 2000) Folic acid reverts dysfunction of endothelial nitric oxid synthase. Circulation Research, 86, 1129 1134.
29. Usui M. Matsuoka H. Miyazaki H. Ueda S. Okuda S. Imaizumi T. ( 1999) Endothelial dysfunction by acute hyperhomocyst(e)inemia: restoration by folic acid. Clinical Science, 96, 235 239.
30. Verhaar M.C. Wever R.M.F. Kastelein J.J.P. van Dam T. Koomans H.A. Rabelink T.J. ( 1998) 5-methyltetrahydrofolate, the active form of folic acid, improves endothelial function in familial hypercholesterolemia. Circulation, 97, 237 241.
31. Verhaar M.C. Stroes E. Rabelink T.J. ( 2002) Folate and cardiovascular disease. Arteriosclerosis Thrombosis and Vascular Biology, 22, 6 13.
32. Vermeulen E.G. Stehouwer C.D. Twisk J.W. van den Berg M. de Jong S.C. Mackaay A.J. van Campen C.M. Visser F.C. Jakobs C.A. Bulterjis E.J. Rauwerda J.A. ( 2000) Effect of homocysteine-lowering treatment with folic acid plus vit. B6 on progression of subclinical atherosclerosis: a randomised placebo-controlled trial. The Lancet, 355, 517 522.
33. Verwei M. Arkbage K. Havenaar R. den Berg H. Witthoft C. Schaafsma G. ( 2003) Folic acid and 5-methyltetrahydrofolate in fortified milk are bioaccessible as determined in a dynamic in vitro gastrointestinal model. Journal of Nutrition, 133, 2377 2383.
34. Voutilainen S. Morrow J.D. Roberts L.J. Alfthan G. Alho H. Nyyssonen K. Salonen J.T. ( 1999) Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arteriosclerosis Thrombosis and Vascular Biology, 19, 1263 1266.
35. Welch G.N. Loscalzo J. ( 1998) Homocysteine and atherothrombosis. New England Journal of Medicine, 338, 1042 1050.
36. Wilmink H.W. Stroes E.S. Erkelens W.D. Gerritsen W.B. Wever R. Banga J.D. Rabelink T.J. ( 2000) Influence of folic acid on postprandial endothelial dysfunction. Arteriosclerosis Thrombosis and Vascular Biology, 20, 185 188.